Next, we studied the expression of MTA3/SOX2 in normal tongue tissue samples, hyperplasia, carcinoma in situ, early invasive carcinoma and invasive carcinoma by immunohistochemistry. This evidence concerns the gene MTA3 and in situ carcinoma.